RE:Regardless ,the die is set..Mayl 2017: ONC announced results from IND.213 and were granted FDA Fast Track designation. At that time they also annoucned they were ready to enter a phase three trial.
SIX YEARS LATER we will have results from their second (PHASE 2) randomized trial in mBC.
That's a long wait for phase 3!
Clearly, if the results tomorrow are anyting less than astounding, ONC will remain unpartnered for Pela/Pax Phase 3 and the SP will be treading water for another half decade.
This does seem like ONC's best shot on net and it better be good. I, for one, cannot bear to see ONC tap the ATM for a couple more years and raise the float well above 100 million shares outstanding.
Times up, let's go.